AVR 0.00% $18.00 anteris technologies ltd

Ann: Admedus announces further data from HSV-2 Trial, page-118

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    Admedus will not need capital raising. They are making their own. Can't wait to see the quarterly numbers soon.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.